EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type 1 diabetes in childhood: Continuous glucose monitoring and automated insulin delivery systems

Raquel Alves Dantas, Ana Beatriz Valença Branco Nunes, Marcelo Andraus Filardi Andorfato, Marcella Porto Sandre Missiatto, Felipe de Souza Fontanella Bittencourt, Bianca Zaia, João Ricardo Magalhães Gonçalves

International Health Sciences Review · 20.11.2026 · 2 (6)

DOI: 10.70164/ihsr.v2i6.280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 20.11.2026. Verfasst von Raquel Alves Dantas und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continuous glucose monitoring (CGM) and automated insulin delivery (AID) have changed the practical management of type 1 diabetes during childhood, when insulin needs, eating patterns, physical activity, and responsibility for care change rapidly. This critical narrative review examines how CGM-derived information and glucose-responsive insulin delivery affect glycemic outcomes, safety, family experience, and equitable implementation. A targeted literature search in 2026 considered pediatric guidelines, randomized trials, and observational evidence indexed in PubMed/MEDLINE and available through official diabetes-society and journal sources. CGM provides actionable information on time in range and hypoglycemia that hemoglobin A1c cannot convey, but its clinical benefit depends on sustained use and interpretation. Pediatric randomized trials demonstrate meaningful gains in time in range with hybrid closed-loop systems across preschool and school ages, without establishing that adverse events or care demands disappear. The evidence also identifies difficulties related to infusion failure, meal announcements, alarms, skin tolerance, school support, and unequal access. The most defensible approach is to offer developmentally appropriate technology early, pair it with structured education and contingency plans, and assess outcomes beyond average glucose, including treatment burden and sustained access. Long-term comparative effectiveness and equitable real-world adoption require further study.

Zitieren

APA

Dantas, R. A., Nunes, A. B. V. B., Andorfato, M. A. F., Missiatto, M. P. S., Bittencourt, F. D. S. F., Zaia, B., & Gonçalves, J. R. M. (2026). Type 1 diabetes in childhood: Continuous glucose monitoring and automated insulin delivery systems. International Health Sciences Review, 2(6). https://doi.org/10.70164/ihsr.v2i6.280

Vancouver

Dantas RA, Nunes ABVB, Andorfato MAF, Missiatto MPS, Bittencourt FDSF, Zaia B, et al. Type 1 diabetes in childhood: Continuous glucose monitoring and automated insulin delivery systems. International Health Sciences Review. 2026;2(6). doi:10.70164/ihsr.v2i6.280

BibTeX
@article{Dantas2026,
  author = {Dantas, Raquel Alves and Nunes, Ana Beatriz Valença Branco and Andorfato, Marcelo Andraus Filardi and Missiatto, Marcella Porto Sandre and Bittencourt, Felipe de Souza Fontanella and Zaia, Bianca and Gonçalves, João Ricardo Magalhães},
  title = {Type 1 diabetes in childhood: Continuous glucose monitoring and automated insulin delivery systems},
  journal = {International Health Sciences Review},
  year = {2026},
  volume = {2},
  number = {6},
  doi = {10.70164/ihsr.v2i6.280}
}
Kostenlos starten →